FDA Drafts Updated Toxin Testing Thresholds For Intraocular Devices
This article was originally published in The Gray Sheet
Executive Summary
After two years of tracking Toxic Anterior Segment Syndrome tied to intraocular devices, FDA issued draft guidance communicating updated endotoxins limits for single-use intraocular ophthalmic devices.